Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients

Forsythoside A Alleviates Imiquimod-Induced Psoriasis-like Dermatitis in Mice by Regulating Th17 Cells and IL-17A Expression

(2022) Hsuan Lin et al.   Journal of Personalized Medicine

Psoriasis

(2021) Christopher E M Griffiths et al.   LANCET

Anti-fibrotic effects of brevilin A in hepatic fibrosis via inhibiting the STAT3 signaling pathway

(2021) Yong Joo Park et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Brevilin A, a Natural Sesquiterpene Lactone Inhibited the Growth of Triple-Negative Breast Cancer Cells via Akt/mTOR and STAT3 Signaling Pathways

(2020) Zhao Qu et al.   OncoTargets and Therapy

Role of Innate Immune Cells in Psoriasis

(2020) Yuki Sato et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Cross-sectional multicenter observational study of psoriatic arthritis in Japanese patients: Relationship between skin and joint symptoms and results of treatment with tumor necrosis factor-α inhibitors

(2019) Noriko Tsuruta et al.   JOURNAL OF DERMATOLOGY

Adaptive and Innate Immunity in Psoriasis and Other Inflammatory Disorders

(2019) Michael P. Schön   Frontiers in Immunology

Brevilin A, a Sesquiterpene Lactone, Inhibits the Replication of Influenza A Virus In Vitro and In Vivo

(2019) Xiaoli Zhang et al.   Viruses-Basel

Brevilin A induces apoptosis and autophagy of colon adenocarcinoma cell CT26 via mitochondrial pathway and PI3K/AKT/mTOR inactivation

(2018) Pengtao You et al.   BIOMEDICINE & PHARMACOTHERAPY

Murine models of psoriasis and their usefulness for drug discovery

(2018) Shih-Yi Chuang et al.   Expert Opinion on Drug Discovery

Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation

(2018) Hui Li et al.   Nature Communications

Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis

(2018) Jason E. Hawkes et al.   JOURNAL OF IMMUNOLOGY

Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities

(2017) James G. Krueger et al.   EXPERIMENTAL DERMATOLOGY

Circulating T-helper 17 cells and associated cytokines in psoriasis

(2016) S. Chhabra et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Qualitative and quantitative analysis of chemical constituents of Centipeda minima by HPLC-QTOF-MS & HPLC-DAD

(2016) Chi-on Chan et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Dynamics and Transcriptomics of Skin Dendritic Cells and Macrophages in an Imiquimod-Induced, Biphasic Mouse Model of Psoriasis

(2015) Dorothea Terhorst et al.   JOURNAL OF IMMUNOLOGY

Using Imiquimod-Induced Psoriasis-Like Skin as a Model to Measure the Skin Penetration of Anti-Psoriatic Drugs

(2015) Yin-Ku Lin et al.   PLoS One

Antioxidant and anti-inflammatory activities of aqueous extract of Centipeda minima

(2013) Shyh-Shyun Huang et al.   JOURNAL OF ETHNOPHARMACOLOGY

Brevilin A, a Novel Natural Product, Inhibits Janus Kinase Activity and Blocks STAT3 Signaling in Cancer Cells

(2013) Xing Chen et al.   PLoS One

Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence

(2012) Rosa Parisi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

What made sesquiterpene lactones reach cancer clinical trials?

(2010) Akram Ghantous et al.   DRUG DISCOVERY TODAY

Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling

(2009) Yeonseok Chung et al.   IMMUNITY

Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis

(2009) L. van der Fits et al.   JOURNAL OF IMMUNOLOGY